Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Universidade de Passo Fundo

ClinicalTrials.gov lists Universidade de Passo Fundo as lead sponsor of 15 trials. It has 5 approved assets.

BR Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

2 0 2008 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Logo Fernando Lopez Anido, via Wikimedia Commons, CC BY-SA 4.0. Shown to identify the organization; it may be a registered trademark.

This page covers Universidade de Passo Fundo: 15 lead-sponsored trials and 1 legal-entity registration.

Get the Universidade de Passo Fundo report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (18)

Shown in this order: most trials first.

Disease areas
Disease area Trials
COVID-19 2
Deglutition Disorders 2
Dyspepsia 2
Gastroesophageal Reflux 2
Cross Infection 1

Trials by start year as sponsor or collaborator (12)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2025 1
2022 1
2020 2
2019 1
2018 1
2017 1
2016 1
2015 2
2014 2
2011 2

Recruitment duration, a model prediction: none of the 15 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (5)

Shown in this order: max phase first.

Approved assets
Drug Trials
Nortriptyline 1
Atropine 1
Prucalopride 1
Buspirone 1
Calcium/Vitamin D 1

Journals published in (29)

Shown in this order: most published in first.

Journals published in
Journal Publications
Dental materials : official publication of the Academy of Dental Materials 2
Oral diseases 2
Alternative therapies in health and medicine 1
American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 1
Annals of surgery 1

Organization relationships (3)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Hospital Nossa Senhora da Conceição Co sponsors trial with 1
Universidade Federal do Rio Grande do Sul Co sponsors trial with 1
Ministry of Science, Technology and Innovation Co sponsors trial with 1

Latest dated events (17)

Shown in this order: newest first.

Latest dated events
Date Event Source
2025-09-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2022-01-06 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2020-09-11 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2020-05-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2019-01-07 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarkers this organization publishes on (11)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
CAT 1
CCND1 1
CXCL8 1
IL1B 1
IL6 1

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.